|Public health ethics: mapping the terrain|
JF Childress, RR Faden, RD Gaare, LO Gostin, J Kahn, RJ Bonnie, ...
The Journal of Law, Medicine & Ethics 30 (2), 170-178, 2002
|Managing incidental findings in human subjects research: analysis and recommendations|
SM Wolf, FP Lawrenz, CA Nelson, JP Kahn, MK Cho, EW Clayton, ...
The Journal of law, medicine & ethics 36 (2), 219-248, 2008
|Managing incidental findings and research results in genomic research involving biobanks and archived data sets|
SM Wolf, BN Crock, B Van Ness, F Lawrenz, JP Kahn, LM Beskow, ...
Genetics in Medicine 14 (4), 361-384, 2012
|Nondirected donation of kidneys from living donors|
AJ Matas, CA Garvey, CL Jacobs, JP Kahn
New England Journal of Medicine 343 (6), 433-436, 2000
|Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype–identical sibling selected using preimplantation genetic diagnosis|
SS Grewal, JP Kahn, ML MacMillan, NKC Ramsay, JE Wagner
Blood 103 (3), 1147-1151, 2004
|Twenty‐two nondirected kidney donors: an update on a single center's experience|
CL Jacobs, D Roman, C Garvey, J Kahn, AJ Matas
American Journal of Transplantation 4 (7), 1110-1116, 2004
|Beyond consent: Seeking justice in research|
JP Kahn, AC Mastroianni, J Sugarman
Oxford University Press, 2018
|Using preimplantation genetic diagnosis to create a stem cell donor: issues, guidelines & limits|
SM Wolf, JP Kahn, JE Wagner
The Journal of Law, Medicine & Ethics 31 (3), 327-339, 2003
|Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage|
RS Gaston, GM Danovitch, RA Epstein, JP Kahn, AJ Matas, MA Schnitzler
American Journal of Transplantation 6 (11), 2548-2555, 2006
|Financial incentives for cadaver organ donation: an ethical reappraisal1|
R Arnold, S Bartlett, J Bernat, J Colonna, D Dafoe, N Dubler, S Gruber, ...
Transplantation 73 (8), 1361-1367, 2002
|Swinging on the pendulum: shifting views of justice in human subjects research|
A Mastroianni, J Kahn
Hastings Center Report 31 (3), 21-28, 2001
|Considerations for the clinical application of chimeric antigen receptor T cells: observations from a recombinant DNA Advisory Committee Symposium held June 15, 2010|
HCJ Ertl, J Zaia, SA Rosenberg, CH June, G Dotti, J Kahn, LJN Cooper, ...
Cancer research 71 (9), 3175-3181, 2011
|Pharmacogenetic challenges for the health care system|
JA Robertson, B Brody, A Buchanan, J Kahn, E McPherson
Health affairs 21 (4), 155-167, 2002
|Pharmacogenetics: ethical issues and policy options|
AE Buchanan, A Califano, JP Kahn, E McPherson, JA Robertson, ...
Kennedy Institute of Ethics Journal 12 (1), 1-15, 2002
|The OHRP and SUPPORT|
BS Wilfond, D Magnus, AH Antommaria, P Appelbaum, J Aschner, ...
N Engl J Med 368 (25), e36, 2013
|Modified atmosphere/vacuum packaging of meat|
Controlled/modified atmosphere/vacuum packaging of foods, 17-37, 1989
|Cell-based interventions for neurologic conditions: ethical challenges for early human trials|
DJH Mathews, J Sugarman, H Bok, DM Blass, JT Coyle, P Duggan, ...
Neurology 71 (4), 288-293, 2008
|Ethics and public health: model curriculum|
B Jennings, J Kahn, AC Mastroianni, LS Parker
Association of Schools of Public Health (ASPH), 2003
|Protecting subjects, preserving trust, promoting progress I: policy and guidelines for the oversight of individual financial interests in human subjects research|
AAMC Task Force on Financial Conflicts of Interest in Clinical Research
Academic Medicine 78 (2), 225-236, 2003
|Research led by participants: a new social contract for a new kind of research|
E Vayena, R Brownsword, SJ Edwards, B Greshake, JP Kahn, N Ladher, ...
Journal of Medical Ethics 42 (4), 216-219, 2016